GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Orchid Pharma ORCHPHARMA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

884.00

+1.84%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

9 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 4Strong buy
  • 4Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Last close 884.00Average target 981.24

Low
909.00
Average
981.24
Median
963.90
High
1,093.05

Forecasts

Analyst averages for the fiscal years ahead

FY2027FY2028
Revenue₹12.88bn₹20.59bn
Revenue, highest₹12.88bn₹21.19bn
Revenue, lowest₹12.88bn₹19.78bn
Earnings per share8.00—
Earnings per share, highest12.10—
Earnings per share, lowest3.90—
Analysts13

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026Q2 2025Q4 2025Q4 2024Q3 2025Q2 2024Q1 2024
Forecast3.633.003.704.496.306.436.905.30
Reported3.634.702.904.404.254.105.806.55
Difference0.0%+56.7%-21.6%-2.0%-32.5%-36.2%-15.9%+23.6%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

2 / 10

Revenue growth -0.6% a year over 10 years. Return on equity 1.6%.

Model fair value

476.62

From earnings 476.62, from revenue 935.44.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.